欧盟撤销艾伯维丙型肝炎药物的上市许可

Reuters
01 Oct 2024

((自动化翻译由路透提供,请见免责声明 ))

路透10月1日 - 欧洲药品管理局周二表示,应艾伯维公司 的丙型肝炎药物Exviera的要求,该局已撤销了该药的上市许可。

监管机构称,它已于9月25日撤销了对该药的授权。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10